By
TB advocates
Published: Feb. 28, 2023, 9 p.m.·
Tags:
Diagnostics,
Access,
Advocacy
Advocates urge Cepheid to take immediate action necessary to bring about affordable, equitable, and expanded access to GeneXpert TB testing.
Read More →
By
World Health Organization
Published: Feb. 28, 2023, 5:53 p.m.·
Tags:
Global TB response,
Advocacy
The World Health Organization releases an advocacy and communications package to support awareness building and drive action across all levels, in the lead up to and on World TB Day.
Read More →
By
Stop TB Partnership
Published: Feb. 22, 2023, 7:18 p.m.·
Tags:
Global TB response,
Advocacy
The Stop TB Partnership releases the toolkit for the World TB Day campaign Yes! We Can End TB.
Read More →
By
Treatment Action Group
Published: Feb. 1, 2023, 4:49 p.m.·
Tags:
Treatment
Treatment Action Group launches the 2022 Tuberculosis Treatment Pipeline Report.
Read More →
By
Stop TB Partnership
Published: Feb. 1, 2023, 1:38 p.m.·
Tags:
Global TB response,
Advocacy
Yes! We Can End TB.
The theme brings attention to TB and that it is in our collective power to end TB by 2030 and therefore reach the Sustainable Development Goals.
Read More →
By
World Health Organization
Published: Jan. 17, 2023, 7:15 p.m.·
Tags:
Global TB response,
Vaccines,
Advocacy
The Council will facilitate the licensing and use of effective novel TB vaccines catalysing high-level alignment between funders, global agencies, governments and end users in identifying and overcoming barriers to TB vaccine development.
Read More →
By
1/4/6x24 Campaign Coalition,
Treatment Action Group
Published: Jan. 17, 2023, 11:46 a.m.·
Tags:
Treatment,
Access,
Advocacy
A few recent Campaign updates from Treatment Action Group and allies.
Contact david.branigan@treatmentactiongroup.org for more information on how to be part of the 1/4/6x24 Campaign.
Read More →
By
TB advocates
Published: Jan. 16, 2023, 9:36 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Access,
Advocacy
Advocates urge Johnson & Johnson to correct its course and stop blocking entry of generic versions of bedaquiline into the global market and into countries.
Read More →
By
Médecins Sans Frontières
Published: Jan. 16, 2023, 6:30 p.m.·
Tags:
Drug-resistant TB,
Treatment,
Access,
Advocacy
Médecins Sans Frontières urges the Indian Patent Office to reject the secondary patent application filed by Johnson & Johnson to prevent the company from extending its monopoly on bedaquiline beyond the primary patent’s expiry in July 2023.
Read More →
By
World Health Organization
Published: Dec. 15, 2022, 8:05 p.m.·
Tags:
Drug-resistant TB,
Guidelines
The World Health Organization releases updated guidelines and a supporting operational handbook on the treatment of drug-resistant TB featuring major improvements in treatment options for people with multidrug-resistant or rifampicin-resistant TB.
Read More →
Page 14 of 133 · Total posts: 10
←First
13
14
15
Last→